Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients

NCT03314493 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Calcification
Vascular Calcification

Interventions

DRUG: Spironolactone 25Mg Tablet

Sponsor

Professor Fernando Figueira Integral Medicine Institute

Collaborators

[object Object]